| Hormone Therapy investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14 |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 36 trials (16 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Prostate Neoplasm 8 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasm 7 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Breast Carcinoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Adenocarcinoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Ductal Carcinoma In Situ 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Ductal Carcinoma In Situ | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Lobular Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Early Stage Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Early Stage HER2-Positive Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Early Stage HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Early Stage Triple-Negative Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Early Stage Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Negative Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Receptor-Positive Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hormone Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oligometastatic Breast Carcinoma 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Oligometastatic Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |